Cystic fibrosis is a genetic disease that causes serious and sometimes fatal respiratory and digestive disorders. A new treatment, available since 2020, improves lung function and quality of life.

Scientists have engineered a living material resembling human phlegm, which will help them to better understand how a certain kind of infection develops on the lungs of patients with cystic fibrosis.

Breathing disorders are common in the U.S. with conditions like COPD affecting some 7% of the population and asthma affecting another 10%. Digestive conditions like GERD, acid reflux, Celiac disease ...

States screen for cystic fibrosis (CF) but with significant variation among their screening algorithms. The Cystic Fibrosis Foundation group conducted a systematic review, leading to seven ...

Please provide your email address to receive an email when new articles are posted on . Over a 16-year period, those with cystic fibrosis vs. sickle cell disease had a larger improvement in mean age ...

Pharmac is proposing to fund new treatment options for people living with cystic fibrosis with eligible mutations, including young children, from 1 April 2026. widening access to Trikafta ...

Please provide your email address to receive an email when new articles are posted on . Food allergy prevalence was lower in those with cystic fibrosis vs. the general pediatric population. The ...